Can miRNA Indicate Risk of Illness after Continuous Exposure to M. tuberculosis?

Cleonardo Augusto Silva1,2, Arthur Ribeiro-Dos-Santos1, Wanderson Gonçalves Gonçalves1,2

  • 1PPG em Genética e Biologia Molecular, Laboratório de Genética Humana e Médica, Universidade Federal do Pará, Belém 66075-110, Brazil.

Insights

This study explored microRNAs (miRNAs) as potential biomarkers for tuberculosis. Three specific miRNAs were identified, suggesting their role in immune response and disease regulation for improved tuberculosis diagnosis.

Area of Science:

  • Molecular Biology
  • Immunology
  • Infectious Diseases

Background:

  • MicroRNAs (miRNAs) are crucial regulatory elements in biological processes, but their role in infectious diseases like tuberculosis remains unclear.
  • Tuberculosis (TB) presents significant challenges in prevention, diagnosis, and treatment, with current therapies causing side effects.
  • Identifying novel biomarkers is essential for improving TB management.

Purpose of the Study:

  • To identify potential biomarkers for tuberculosis using next-generation sequencing (NGS) techniques.
  • To investigate global miRNA expression profiles in tuberculosis patients compared to healthy controls.
  • To explore the role of differentially expressed miRNAs in the immune physiopathology of tuberculosis.

Main Methods:

  • Collected blood samples from tuberculosis patients (n=9), their healthy physicians (n=6), and external healthy controls (n=7).
  • Applied NGS to obtain global miRNA expression profiles.
  • Utilized differential expression analysis, target gene prediction, gene set enrichment, and miRNA-gene network analyses.

Main Results:

  • Identified 153 differentially expressed miRNAs.
  • Found three specific differentially expressed miRNAs (hsa-let-7g-5p, hsa-miR-486-3p, and hsa-miR-4732-5p) between tuberculosis patients and their physicians.
  • These miRNAs are implicated in granuloma regulation and immune response.

Conclusions:

  • MicroRNAs play a role in immune modulation by regulating gene expression in immune cells.
  • The identified miRNAs show potential as biomarkers for tuberculosis diagnosis and understanding disease mechanisms.
  • Further research into miRNAs could lead to improved diagnostic tools and therapeutic strategies for tuberculosis.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
257
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
450
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
797
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
566
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
302